{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T01:29:28Z","timestamp":1776302968536,"version":"3.50.1"},"reference-count":16,"publisher":"Informa UK Limited","issue":"11","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Biological Therapy"],"published-print":{"date-parts":[[2023,11,2]]},"DOI":"10.1080\/14712598.2023.2277408","type":"journal-article","created":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T13:44:58Z","timestamp":1698673498000},"page":"1049-1052","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["What\u2019s new in the use of antibody-drug conjugates (ADCs) delivering pyrrolobenzodiazepine (PBD) DNA cross-linkers for cancer therapy?"],"prefix":"10.1080","volume":"23","author":[{"given":"John A","family":"Hartley","sequence":"first","affiliation":[{"name":"UCL Cancer Institute, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,10,31]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2020.1776255"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020007512"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00139-X"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(21)00103-4"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000843696.37630.1c"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000971424.40251.1c"},{"key":"e_1_3_3_8_1","volume-title":"(Abstract) 10th Annual Meeting of the Society of Hematologic Oncology","author":"Kingsley E","year":"2022","unstructured":"Kingsley E, Grosicki S, Kwiatek M, et al. Initial safety run-in results of the phase 3 LOTIS-5 trial: novel combination of loncastuximab tesirine with rituximab (Lonca-R) versus immunochemotherapy in patients with R\/R DLBCL. (Abstract) 10th Annual Meeting of the Society of Hematologic Oncology; 2022 Sep 28 Oct; Houston, TX. Abstract ABCL-320."},{"key":"e_1_3_3_9_1","unstructured":"https:\/\/ir.adctherapeutics.com\/press-releases\/press-release-details\/2023\/ADC-Therapeutics-Announces-Voluntary-Pause-of-Enrollment-in-the-Phase-2-LOTIS-9-Clinical-Trial-of-ZYNLONTA-loncastuximab-tesirine-lpyl-and-Rituximab-in-Unfit-or-Frail-Previously-Untreated-DLBCL-Patients\/default.aspx."},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-170730"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-4528"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-21-0715"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-137004"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2020.106385"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-03-841171"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-28533-4"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-22-0145"}],"container-title":["Expert Opinion on Biological Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14712598.2023.2277408","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T23:35:48Z","timestamp":1727220948000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14712598.2023.2277408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,31]]},"references-count":16,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11,2]]}},"alternative-id":["10.1080\/14712598.2023.2277408"],"URL":"https:\/\/doi.org\/10.1080\/14712598.2023.2277408","relation":{},"ISSN":["1471-2598","1744-7682"],"issn-type":[{"value":"1471-2598","type":"print"},{"value":"1744-7682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,31]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-08-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}